<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Suppositories of <z:chebi fb="0" ids="132842">sulphapyridine</z:chebi>, <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi>, and placebo were used in 45 patients with idiopathic <z:mp ids='MP_0003305'>proctitis</z:mp> to determine the active part of sulphasalazine </plain></SENT>
<SENT sid="1" pm="."><plain>Each patient used one of the suppositories twice daily for four weeks in a double-blind controlled trial </plain></SENT>
<SENT sid="2" pm="."><plain>Complete clinical remission with <z:mpath ids='MPATH_458'>normal</z:mpath> rectal mucosa on sigmoidoscopy occurred in 60% of patients given <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi>, but in only 13% and 27% of those given <z:chebi fb="0" ids="132842">sulphapyridine</z:chebi> and placebo respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Twelve patients were included twice </plain></SENT>
<SENT sid="4" pm="."><plain>In eight of these patients <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi> was given one time and <z:chebi fb="0" ids="132842">sulphapyridine</z:chebi> (two patients) or placebo (six patients) another time </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical remission occurred in each patient with <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi>, but in only one patient during other therapy </plain></SENT>
<SENT sid="6" pm="."><plain>The results suggest that <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi> is the active therapeutic moiety of sulphasalazine </plain></SENT>
</text></document>